Immunological induction of T lymphocytes: role of antigen and the lymphocyte costimulator
- PMID: 95670
Immunological induction of T lymphocytes: role of antigen and the lymphocyte costimulator
Abstract
In vitro T cell activation requires both antigen presentation and a second stimulus provided by the lymphocyte costimulator. Neither alone is sufficient to induce specific T cell activation. The S+ phenotype of stimulating cells is dependent on the metabolic activity of these cells. This finding is consistent with the notion that production and/or release of the costimulator is a function of metabolically active cells. The costimulator acts at an early stage of the interaction between lymphocyte and antigen, and the costimulator, or a separate maintenance factor, is required throughout the culture period for the expression of full cytotoxic activity. The lymphocyte costimulator is not strain specific but is phylogenetically specific. The activation of cytotoxic T cells by S+ cells is also phylogenetically specific, and this specificity of cellular activation can be accounted for by the species specificity of the lymphocyte costimulator.
Similar articles
-
Effects of costimulator on immune responses in vitro.J Immunol. 1978 Jun;120(6):1974-80. J Immunol. 1978. PMID: 149174
-
Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system.J Immunol. 1986 Apr 15;136(8):2832-8. J Immunol. 1986. PMID: 2420871
-
Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.J Immunol. 1975 Jan;114(1 Pt 1):206-10. J Immunol. 1975. PMID: 122986
-
The antigen-specific signal in T-lymphocyte activation by alloantigen.Nouv Rev Fr Hematol (1978). 1979;21(2):149-60. Nouv Rev Fr Hematol (1978). 1979. PMID: 92782 Review.
-
Interaction of T cells with the epidermis.Br J Dermatol. 1982 Jul;107(1):117-22. doi: 10.1111/j.1365-2133.1982.tb00299.x. Br J Dermatol. 1982. PMID: 6179529 Review. No abstract available.
Cited by
-
Checkpoint inhibitors in lung cancer: latest developments and clinical potential.Ther Adv Med Oncol. 2016 Nov;8(6):460-473. doi: 10.1177/1758834016661164. Epub 2016 Jul 26. Ther Adv Med Oncol. 2016. PMID: 27800034 Free PMC article. Review.
-
The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses.J Immunol. 2023 Mar 1;210(5):521-530. doi: 10.4049/jimmunol.2200672. J Immunol. 2023. PMID: 36881868 Free PMC article.
-
Long-term culture of normal mouse B lymphocytes.Proc Natl Acad Sci U S A. 1981 Sep;78(9):5788-92. doi: 10.1073/pnas.78.9.5788. Proc Natl Acad Sci U S A. 1981. PMID: 6795635 Free PMC article.
-
The history of the two-signal model of lymphocyte activation: A personal perspective.Scand J Immunol. 2019 Jun;89(6):e12762. doi: 10.1111/sji.12762. Epub 2019 Mar 18. Scand J Immunol. 2019. PMID: 30825214 Free PMC article. Review.
-
A Plausible Framework Reveals Potential Similarities in the Regulation of Immunity against Some Cancers and Some Infectious Agents: Implications for Prevention and Treatment.Cancers (Basel). 2024 Apr 7;16(7):1431. doi: 10.3390/cancers16071431. Cancers (Basel). 2024. PMID: 38611110 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources